License

License Not Specified

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

A Randomized Open-Label Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients with X-linked Hypophosphatemia XLH

Evaluate the effect of KRN23 therapy in improving rickets in children with XLH compared with active control oral phosphateactive vitamin D

FieldValue
Modified
2019-12-23
Release Date
2019-05-09
Identifier
0561444d-710e-4e5e-9916-03fae2352529
License
License Not Specified
Public Access Level
Public